# Karkinos Healthcare Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/karkinos-healthcare-private

- Industry: Medical Devices & Equipment
- Headquarters: Mumbai, India
- Website: www.karkinos.in
- Total disclosed funding: $15M
- Latest round: Series A (Dec 31, 2021)
- Investors on record: 8

## About

Karkinos Healthcare, based in Mumbai, India, is a technology-driven oncology platform that provides comprehensive cancer care through advanced diagnostics, teleconsultation, and personalized treatment plans.Karkinos Healthcare Private Limited is focused on oncology services, offering innovative cancer care solutions. Founded in 2020 in Mumbai, India, the company has executed 6 deals to date. The latest funding round, an Add-on Trade Sale in December 2024, raised INR 3.75 billion, led by Reliance Industries Limited, bringing the total amount raised to INR 1,662.75 million. The company was co-founded by Deepak Kharwad, Manish Sharma, Moni Kuriakose, Raja Kommu, Shahvir Nooryezdan, Sundar Raman, and Venkataramani S serves as the CEO.Karkinos Healthcare operates as a technology-led oncology platform that focuses on delivering comprehensive cancer care. Its primary offerings include advanced diagnostic services, teleconsultation with oncology experts, personalized treatment plans, and patient navigation through its Command Center. The platform aims to facilitate early cancer detection and provide tailored treatment options, employing technologies like Next-Generation Sequencing (NGS) and clinical genomics to support personalized medicine. Karkinos Healthcare serves a diverse client base that includes cancer patients, healthcare providers, and institutions across India and select international markets, ensuring that patients receive support throughout their treatment journey.In 2023, Karkinos Healthcare generated revenue of INR 2,730,072.30, with an EBITDA of INR -17,594,786.50. The firm’s revenue primarily comes from subscription services and direct consultations, establishing partnerships with healthcare providers and hospitals to ensure a seamless referral system for specialized oncology services. The pricing structure reflects the high-quality care and advanced technology utilized in their offerings, providing comprehensive cancer management solutions.Karkinos Healthcare plans to leverage the recent acquisition by Reliance Industries Limited to enhance its technology-driven cancer detection and treatment solutions. As part of its growth strategy, the company is expected to expand into additional international markets by integrating its services into Reliance's extensive healthcare network. The latest funding will support the development of new products and technology enhancements, aiming for significant expansion by 2025.

## Funding rounds

- Series A, Dec 31, 2021, $15M — Tata Sons Private Limited, Z Nation Lab, Dreamweaver Investments and Business Solutions, Escondido Ventures, Reliance Industries Limited, Patni Wealth Advisors, QED Innovation Labs, Sigurd Venture

## Investors

- Tata Sons Private Limited — Series A
- Z Nation Lab (https://capitalatlas.ai/funds/z-nation-lab) — Series A
- Dreamweaver Investments and Business Solutions — Series A
- Escondido Ventures — Series A
- Reliance Industries Limited — Series A
- Patni Wealth Advisors — Series A
- QED Innovation Labs — Series A
- Sigurd Venture (https://capitalatlas.ai/funds/sigurd-venture) — Series A